[Federal Register Volume 85, Number 54 (Thursday, March 19, 2020)]
[Notices]
[Pages 15814-15815]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05748]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Ainistration

[Docket No. DEA-591]


Bulk Manufacturer of Controlled Substances Application: Siegfried 
USA, LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before May 18, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on November 6, 2019, Siegfried USA, LLC, 33 Industrial 
Park Road, Pennsville, New Jersey 08070-3244 applied to be registered 
as a bulk manufacturer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid..............     2010  I
Dihydromorphine........................     9145  I
Hydromorphinol.........................     9301  I
Methylphenidate........................     1724  II
Amobarbital............................     2125  II
Pentobarbital..........................     2270  II
Secobarbital...........................     2315  II
Codeine................................     9050  II
Oxycodone..............................     9143  II

[[Page 15815]]

 
Hydromorphone..........................     9150  II
Hydrocodone............................     9193  II
Methadone..............................     9250  II
Methadone intermediate.................     9254  II
Morphine...............................     9300  II
Oripavine..............................     9330  II
Thebaine...............................     9333  II
Opium tincture.........................     9630  II
Oxymorphone............................     9652  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for sale to its customers.

    Dated: February 10, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-05748 Filed 3-18-20; 8:45 am]
 BILLING CODE 4410-09-P